Bio-Rad Laboratories Net Income

Bio-Rad Laboratories (BIO) currently reports a net income of $220M as of June 2026. That compares with $260M in the prior-year period — down 12.9% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Bio-Rad Laboratories's net income history and peer comparisons.

Bio-Rad Laboratories's net income decreased from $260M to $220M — a 12.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bio-Rad Laboratories's net income of $220M is lower than the Healthcare sector average of $16B. That is roughly 98.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Bio-Rad Laboratories reported $220M in net income as of June 2026. That compares with $260M in the prior-year period — down 12.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Bio-Rad Laboratories, and consider following BIO for alerts when major investors trade the stock.